Skip to main content

Advertisement

SpringerLink
Log in

Evaluation of paraoxonase and arylesterase activities in Egyptian patients with ankylosing spondylitis

  • Original Article
  • Published:
Rheumatology International Aims and scope Submit manuscript

Abstract

The role of paraoxonase (PON) and arylesterase (ARE) in the pathogenesis of inflammatory arthritis has been investigated, and their serum levels have been evaluated, but clinical study concerning PON1 and ARE and ankylosing spondylitis (AS) is little reported in literature. The aim of this study was to investigate PON1 and ARE activities in AS in comparison with healthy persons and their relation with the disease activity parameters. 35 AS patients and 35 healthy controls (matched for age and sex) participated. Disease activity of AS patients was assessed clinically according to the Bath AS disease activity index, and AS functional impairment was assessed using the Bath AS Functional Index. Serum samples were collected from all subjects to evaluate serum PON1, ARE activities, and lipid profile. The mean serum triglycerides, total cholesterol, and low density lipoprotein (LDL) were significantly higher in the AS patients than in controls, while the high-density lipoprotein (HDL) is significantly lower in the AS patients than controls. Serum PON1 and ARE activities were significantly lower in AS patients than in controls, while malondialdehyde (MDA) was significantly higher. AS patients with active disease had significantly higher serum triglycerides, total cholesterol, LDL and MDA while lower HDL, PON1 and ARE than those with no active AS. Decrease in the PON1/ARE activity leading to generation of oxidative stress may play an important role in the pathogenesis of AS. Moreover, it seems that activity of PON1/ARE in patients with AS is strictly correlated with the activity of the inflammatory process.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Halliwell B (1994) Free radicals, antioxidants, and human disease: curiosity, cause, or consequence? Lancet 344:721–724

    Article  CAS  Google Scholar 

  2. Gambhir JK, Lali P, Jain AK (1997) Correlation between blood antioxidant levels and lipid peroxidation in rheumatoid arthritis. Clin Biochem 30:351–355

    Article  CAS  Google Scholar 

  3. Halliwell B (1996) Antioxidants in human health and disease. Annu Rev Nutr 16:33–50

    Article  CAS  Google Scholar 

  4. Mazzetti I, Grigolo B, Pulsatelli L et al (2001) Differential roles of nitric oxide and oxygen radicals in chondrocytes affected by osteoarthritis and rheumatoid arthritis. Clin Sci (Lond) 101:593–599

    Article  CAS  Google Scholar 

  5. Hadjigogos K (2003) The role of free radicals in the pathogenesis of rheumatoid arthritis. Panminerva Med 45:7–13

    CAS  PubMed  Google Scholar 

  6. Mackness MI, Mackness B, Durrington PN, Connelly PW et al (1996) Paraoxonase: biochemistry, genetics and relationship to plasma lipoproteins. Curr Opin Lipidol 7:69–76

    Article  CAS  Google Scholar 

  7. Aviram M, Rosenblat M, Bisgaier CL, Newton RS et al (1998) Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase. J Clin Invest 101:1581–1590

    Article  CAS  Google Scholar 

  8. Feingold KR, Memon RA, Moser AH, Grunfeld C (1998) Paraoxonase activity in the serum and hepatic mRNA levels decrease during the acute phase response. Atherosclerosis 139:307–315

    Article  CAS  Google Scholar 

  9. Mackness B, Mackness MI, Arrol S, Turkie W et al (1998) Effect of the human serum paraoxonase 55 and 192 genetic polymorphisms on the protection by high density lipoprotein against low density lipoprotein oxidative modification. FEBS Lett 423:57–60

    Article  CAS  Google Scholar 

  10. Rozenberg O, Rosenblat M, Coleman R, Shih DM et al (2003) Paraoxonase (PON1) deficiency is associated with increased macrophage oxidative stress: studies in PON1-knockout mice. Free Radic Biol Med 34:774–784

    Article  CAS  Google Scholar 

  11. Karakaya A, Suzen S, Sardas S, Karakaya AE, Vural N (1991) Analysis of the serum paraoxonase/arylesterase polymorphism in a Turkish population. Pharmacogenetics 1:58–61

    Article  CAS  Google Scholar 

  12. Serdar Z, Aslan K, Dirican M, Sarandol E, Yesilbursa D, Serdar A (2006) Lipid and protein oxidation and antioxidant status in patients with angiographically proven coronary artery disease. Clin Biochem 39:794–803

    Article  CAS  Google Scholar 

  13. Elkiran ET, Mar N, Aygen B, Gursu F, Karaoglu A, Koca S (2007) Serum paraoxonase and arylesterase activities in patients with lung cancer in a Turkish population. BMC Cancer 7:48–55

    Article  Google Scholar 

  14. Gan KN, Smolen A, Eckerson HW, La Du BN (1991) Purification of human serum paraoxonase/arylesterase. Evidence for one esterase catalyzing both activities. Drug Metab Dispos 19:100–106

    CAS  PubMed  Google Scholar 

  15. Kataria RK, Brent LH (2004) Spondyloarthropathies. Am Fam Physician 69:2853–2860

    PubMed  Google Scholar 

  16. Karakoc M, Altindag O, Keles H, Soran N, Selek S (2007) Serum oxidative–antioxidative status in patients with ankylosing spondilitis. Rheumatol Int 27:1131–1134

    Article  CAS  Google Scholar 

  17. Erdem FH, Karatay S, Yildirim K, Kiziltunc A (2010) Evaluation of serum paraoxonase and arylesterase activities in ankylosing spondylitis patients. Clinics 65(2):175–179

    Article  Google Scholar 

  18. van der Linden S, Valkenburg HA, Cats A (1984) Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 27(4):361–368

    Article  Google Scholar 

  19. Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A (1994) A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 21(12):2286–2291

    CAS  PubMed  Google Scholar 

  20. Calin A, Garrett S, Whitelock H, Kennedy LG, O’Hea J, Mallorie P et al (1994) A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. J Rheumatol 21:2281–2285

    CAS  PubMed  Google Scholar 

  21. Eckerson HW, Wyte MC, La Du BN (1983) The human serum paraoxonase/arylesterase polymorphism. Am J Hum Genet 35:1126–1138

    CAS  PubMed  PubMed Central  Google Scholar 

  22. Haagen L, Brock A (1992) A new automated method for phenotyping arylesterase (E.C.3.1.1.2.) based upon inhibition of enzymatic hydrolysis of 4-nitrophenyl acetate by phenyl acetate. Eur J Clin Chem Clim Biochem 30:391–395

    CAS  Google Scholar 

  23. Ohkawa H, Ohisi N, Yagi K (1979) Assay for peroxides in animal tissue by thiobarbituric acid reaction. Ann Biochem 95:351–358

    Article  CAS  Google Scholar 

  24. Reddy ST, Wadleigh DJ, Grijalva V et al (2001) Human paraoxonase-3 is an HDL-associated enzyme with biological activity similar to paraoxonase-1 protein but is not regulated by oxidized lipids. Arterioscler Thromb Vasc Biol 21:542–547

    Article  CAS  Google Scholar 

  25. Collins AR (2005) Assays for oxidative stress and antioxidant status: applications to research into the biological effectiveness of polyphenols. Am J Clin Nutr 81(suppl 1):261S–267S

    Article  CAS  Google Scholar 

  26. Tanimoto N, Kumon Y, Suehiro T, Ohkubo S et al (2003) Serum paraoxonase activity decreases in rheumatoid arthritis. Life Sci 72:2877–2885

    Article  CAS  Google Scholar 

  27. Baskol G, Demir H, Baskol M, Kilic E et al (2005) Assessment of paraoxonase 1 activity and malondialdehyde levels in patients with rheumatoid arthritis. Clin Biochem 38:951–955

    Article  CAS  Google Scholar 

  28. Ozgocmen S, Sogut S, Fadıllıoglu E, Ardicoglu A, Ardicoglu O (2003) Antioxidant status and lipid peroxidation in seminal plasma and spermatozoa of patients with ankylosing spondylitis. Rheumatology 42:805–807

    Article  CAS  Google Scholar 

  29. Ozgocmen S, Sogut S, Ardicoglu O, Fadillioglu E, Pekkutucu I, Akyol O (2004) Serum nitric oxide, catalase, superoxide dismutase, and malondialdehyde status in patients with ankylosing spondylitis. Rheumatol Int 24:80–83

    Article  CAS  Google Scholar 

  30. Stanek A, Cieślar G, Romuk E, Kasperczyk S, Sieroń-Stołtny K, Birkner E, Sieroń A (2010) Decrease in antioxidant status of plasma and erythrocytes from patients with ankylosing spondylitis. Clin Biochem 43(6):566–570 (epub 4 Jan 2010)

    Article  CAS  Google Scholar 

  31. Cece H, Yazgan P, Karakas E, Karakas O, Demirkol A, Toru I, Aksoy N (2011) Carotid intima-media thickness and paraoxonase activity in patients with ankylosing spondylitis. Clin Invest Med 34(4):E225

    Article  CAS  Google Scholar 

  32. Canales A, Sanchez-Muniz FJ (2003) Paraoxanase, something more than an enzyme? Med Clin (Barc) 121:537–548 (Spanish)

    Article  Google Scholar 

  33. Steinberg D (1997) Low density lipoprotein oxidation and its pathobiological significance. J Biol Chem 272:20963–20966

    Article  CAS  Google Scholar 

  34. Laplaud PM, Dantoine T, Chapman MJ (1998) Paraoxonase as a risk marker for cardiovascular disease: facts and hypotheses. Clin Chem Lab Med 37:431–441

    Google Scholar 

  35. Jakubowski H (2005) Anti-N-homocysteinylated protein autoantibodies and cardiovascular disease. Clin Chem Lab Med 43:1011–1014

    Article  CAS  Google Scholar 

Download references

Conflict of interest

None.

Author information

Authors and Affiliations

  1. Department of Rheumatology and Rehabilitation, Mansoura University Hospital, Mansoura, Egypt

    Shereem Mohamed Olama

  2. Department of Clinical Pathology, Faculty of Medicine, Mansoura University, Mansoura, Egypt

    Mohammed Mohamed Elarman

Authors
  1. Shereem Mohamed Olama
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mohammed Mohamed Elarman
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Shereem Mohamed Olama.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Olama, S.M., Elarman, M.M. Evaluation of paraoxonase and arylesterase activities in Egyptian patients with ankylosing spondylitis. Rheumatol Int 33, 1487–1494 (2013). https://doi.org/10.1007/s00296-012-2591-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00296-012-2591-1

Keywords

Search

Navigation